OPSYS Injectable SUI Treatment, the latest development by Promedon for the treatment of male and female urinary incontinence, will be launched to the world market in 2010.

Opsys is a non-absorbable injectable agent with improved biomechanical performance, which creates a stable bulk with very low inflammatory reaction. It can be easily injected using 21-G injection needles.

With the launch of this bulking agent, Promedon is positioned as a company with the largest portfolio of solutions for the treatment of male and female stress urinary incontinence, including: Adjustable slings, tension-free polypropylene slings and single-incision mini slings.

Promedon is the only worldwide company which provides surgeons with a wide range of solutions allowing to choose the option according to the condition of each patient.